FDA Would Ease AER Requirements During Flu Pandemic
This article was originally published in The Tan Sheet
Executive Summary
FDA would suspend some mandatory adverse event reports for drug and dietary supplement manufacturers temporarily during a widespread flu pandemic, according to a draft guidance